CompletedPhase 3

Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer

France152 participantsStarted 2013-02

Plain-language summary

The purpose of this study is to assess the efficacy and safety of T4020 versus vehicle.

Who can participate

Age range18 Years – 95 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients diagnosed with one chronic keratitis/corneal ulcer * Patients who signed and dated informed consent Exclusion Criteria: * Patient under 18 years * Patient with a perforated corneal ulcer OR any risk of immediate perforation of corneal ulcer.

What they're measuring

Number of Participants With a Reduction in Neurotrophic the Keratitis/Ulcer Area on Day28

Timeframe: Day 28

Trial details

NCT IDNCT01794312

SponsorLaboratoires Thea

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2017-12-19

Results submitted2019-07-16

View on ClinicalTrials.gov More Keratitis trials